These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11243135)

  • 1. [Leu 72 Pro mutation in the NADH-cytochrome b5 reductase gene found in a Chinese hereditary methemoglobinemia patient].
    Wu Y; Huang C; Zhu Z
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):195-7. PubMed ID: 11243135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel point mutation in NADH-cytochrome b5 reductase gene].
    Wang Y; Wu Y; Yang W
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):521-3. PubMed ID: 11721397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular analysis of the structure of the mutant NADH-cytochrome b5 reductase gene causing methemoglobinemia].
    Kobayashi Y
    Fukuoka Igaku Zasshi; 1990 Jan; 81(1):41-7. PubMed ID: 2323714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) gene.
    Kugler W; Pekrun A; Laspe P; Erdlenbruch B; Lakomek M
    Hum Mutat; 2001 Apr; 17(4):348. PubMed ID: 11295830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis.
    Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA
    Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel point mutation (Leu72Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I.
    Wu YS; Huang CH; Wan Y; Huang QJ; Zhu ZY
    Br J Haematol; 1998 Jul; 102(2):575-7. PubMed ID: 9695975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia.
    Wang Y; Wu YS; Zheng PZ; Yang WX; Fang GA; Tang YC; Xie F; Lan FH; Zhu ZY
    Blood; 2000 May; 95(10):3250-5. PubMed ID: 10807796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type.
    Kobayashi Y; Fukumaki Y; Yubisui T; Inoue J; Sakaki Y
    Blood; 1990 Apr; 75(7):1408-13. PubMed ID: 2107882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A compound heterozygote in the NADH-cytochrome b5 reductase gene from a Chinese patient with hereditary methemoglobinemia type I.
    Wu YS; Wang Y; Huang CH; Lan FH; Zhu ZY
    Int J Hematol; 2000 Jul; 72(1):34-6. PubMed ID: 10979206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation of the cytochrome-b5 reductase gene in an Indian patient: the molecular basis of type I methemoglobinemia.
    Nussenzveig RH; Lingam HB; Gaikwad A; Zhu Q; Jing N; Prchal JT
    Haematologica; 2006 Nov; 91(11):1542-5. PubMed ID: 17082011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia.
    Kedar PS; Warang P; Nadkarni AH; Colah RB; Ghosh K
    Blood Cells Mol Dis; 2008; 40(3):323-7. PubMed ID: 17964195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia.
    Yubisui T; Murakami K; Shirabe K; Takeshita M; Zenno S; Tomatsu S; Fukumaki Y
    Prog Clin Biol Res; 1989; 319():107-19; discussion 120-1. PubMed ID: 2695933
    [No Abstract]   [Full Text] [Related]  

  • 13. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia.
    Manabe J; Arya R; Sumimoto H; Yubisui T; Bellingham AJ; Layton DM; Fukumaki Y
    Blood; 1996 Oct; 88(8):3208-15. PubMed ID: 8874222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation found in the 3' domain of NADH-cytochrome B5 reductase in an African-American family with type I congenital methemoglobinemia.
    Jenkins MM; Prchal JT
    Blood; 1996 Apr; 87(7):2993-9. PubMed ID: 8639921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.
    Shirabe K; Landi MT; Takeshita M; Uziel G; Fedrizzi E; Borgese N
    Am J Hum Genet; 1995 Aug; 57(2):302-10. PubMed ID: 7668255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene.
    Fermo E; Bianchi P; Vercellati C; Marcello AP; Garatti M; Marangoni O; Barcellini W; Zanella A
    Blood Cells Mol Dis; 2008; 41(1):50-5. PubMed ID: 18343696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of recessive congenital methemoglobinemia in Chinese pedigrees.
    Wang Y; Huang C; Wu Y; Lan F; Tang Y; Zhu Z
    Chin Med J (Engl); 1999 Nov; 112(11):1032-5. PubMed ID: 11721467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification.
    Jaffé ER
    Blood Cells; 1986; 12(1):81-90. PubMed ID: 3539237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary methemoglobinemia due to NADH cytochrome b5 abnormality--clinical importance of the enzyme in leukocytes and platelets].
    Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Meguro T; Yamada K; Fujii H; Takizawa T; Miwa S
    Rinsho Ketsueki; 1986 Mar; 27(3):412-9. PubMed ID: 3735692
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
    Percy MJ; Crowley LJ; Roper D; Vulliamy TJ; Layton DM; Barber MJ
    Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.